arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2005.01042q-bio.CB
收藏

SARS-CoV-2感染的转录景观阻碍了病毒激活的致病途径,提出了独特的性别特异性差异,并预测了定制的治疗策略

Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies

Paolo Fagone, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, Klaus Bendtzen, Placido Bramanti, Ferdinando Nicoletti

摘要:

严重急性呼吸道综合征冠状病毒2型(SARS-CoV-2)疾病(COVID-19)的出现对全球健康构成了严重威胁。由于目前还没有特定的治疗方法来控制疾病的演变,因此更深入地了解SARS-CoV-2诱导的致病机制将有助于描述COVID-19管理的新靶点。本研究确定了一组特定的生物学途径改变后,SARS冠状病毒-2感染的原代人肺上皮细胞,并与2003年的SARS冠状病毒大流行进行了比较研究。转录组学谱也被用作可能的新的治疗靶点,并且反签名扰动分析预测了控制疾病进展的潜在药物。其中,丝裂原活化蛋白激酶激酶(MEK)、丝氨酸-苏氨酸激酶(AKT)、哺乳动物雷帕霉素靶蛋白(mTOR)和I κ B激酶(IKK)抑制剂成为候选药物。最后,提出了可能导致男性COVID-19死亡率较高的性别特异性差异。

英文摘要:

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has posed a serious threat to global health. As no specific therapeutics are yet available to control disease evolution, more in-depth understanding of the pathogenic mechanisms induced by SARS-CoV-2 will help to characterize new targets for the management of COVID-19. The present study identified a specific set of biological pathways altered in primary human lung epithelium upon SARS-CoV-2 infection, and a comparison with SARS-CoV from the 2003 pandemic was studied. The transcriptomic profiles were also exploited as possible novel therapeutic targets, and anti-signature perturbation analysis predicted potential drugs to control disease progression. Among them, Mitogen-activated protein kinase kinase (MEK), serine-threonine kinase (AKT), mammalian target of rapamycin (mTOR) and I kappa B Kinase (IKK) inhibitors emerged as candidate drugs. Finally, sex-specific differences that may underlie the higher COVID-19 mortality in men are proposed.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑